Highlights Viyash Scientific Limited

Equities

VIYASH

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:21:36 2026-03-06 am EST			5-day change	1st Jan Change
203.00 ^INR	+0.47%		-4.54%	-2.47%

Feb. 13	Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026	CI
Feb. 06	Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026

Highlights

Feb. 06	Viyash Scientific Limited to Seek Selective Mergers and Acquisitions	CI
Feb. 05	Viyash Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
Jan. 07	Sequent Scientific Limited completed the acquisition of Viyash Life Sciences Private Limited.	CI
Nov. 14	Sequent Scientific Sept-quarter consol net profit 147.4 million rupees	RE
Nov. 14	Sequent Scientific Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-08	Sequent Scientific's Consolidated Profit Jumps in Fiscal Q1	MT
25-08-08	Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-20	Viyash Scientific Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-05-20	Sequent Scientific March-Quarter Consol Net Profit 93.2 Million Rupees	RE
25-02-11	Viyash Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
24-11-13	Sequent Scientific Limited Seeks M&A	CI
24-11-13	Sequent Scientific Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
24-09-26	Sequent Scientific and Viyash Life Sciences Reportedly Explore Merger Worth INR 70,000 Million-INR 80,000 Million	CI
24-09-25	Sequent Scientific Limited agreed to acquire Viyash Life Sciences Private Limited for INR 38 billion.	CI
24-08-19	Sequent Scientific Gets WHO Nod for Albendazole Active Pharmaceutical Ingredient	MT
24-08-19	Sequent Scientific Limited Receives WHO Prequalification Approval for Albendazole API	CI
24-08-14	Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-05-16	Sequent Scientific Limited Seeks M&A	CI
24-05-15	Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
24-05-15	Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
24-02-13	Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
23-08-10	Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI
23-05-23	Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	CI
23-03-08	SeQuent Scientific Terminates Agreement to Acquire Tineta Pharma	MT
23-03-07	Sequent Scientific Limited cancelled the acquisition of Tineta Pharma Private Limited from group of shareholders.	CI